Trials / Not Yet Recruiting
Not Yet RecruitingNCT06766513
Characterization of the Sleep-Wake Cycle in Traumatic Brain Injury Patients with a Disorder of Consciousness
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Each year in France, 160,000 peoples suffer from a mild or severe traumatic brain injury (TBI). Sleep plays a crucial role in the process of brain plasticity, which is essential for neurological and cognitive recovery. However, the sleep-wake cycle is rarely, if ever, evaluated in patients with TBI and consciousness disorders within Post-Resuscitation Rehabilitation Units (SRPR). Caregivers develop, on a daily basis, an intuitive understanding of the patient's overall condition. This expertise deserves to be validated using objective sleep assessment tools (actigraphy). If proven accurate, it could lead to the implementation of a sleep-wake cycle evaluation protocol within SRPRs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Actimetry | actimetry will be performed continuously during these 104 hours. |
| OTHER | Subjective assessments | The subjective assessments of the patient's awake/sleep state will be collected every 2 hours during the night and at least 3 times during the day, for a total of at least 8 assessments per 24-hour period, over a duration of 104 consecutive hours (slightly more than 4 days, starting at midnight and ending at 8 :00 AM, to cover 4 full days and 4 full nights). |
| OTHER | questionnaire | MOCA : Montreal Cognitive Assessment |
| OTHER | questionnaire | SF-36 The Short Form (36) |
| OTHER | questionnaire | CRS-R (Coma Recovery Scale-Revised) |
| OTHER | questionnaire | GOSE (Glasgow Outcome Scale-Extended) |
| OTHER | questionnaire | GCS (Glasgow Coma Scale) |
Timeline
- Start date
- 2025-02-01
- Primary completion
- 2028-02-01
- Completion
- 2028-08-01
- First posted
- 2025-01-09
- Last updated
- 2025-01-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06766513. Inclusion in this directory is not an endorsement.